In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
University of Southern California
Thomas Jefferson University
Thomas Jefferson University
Centre Hospitalier Universitaire Vaudois
Stanford University
Adaptimmune
Pfizer
Duke University